SELPLG and autoimmune polyendocrinopathy: By profiling the transcriptome of APS neutrophils, we have discovered a strikingly activated signature in APS neutrophils as compared with controls13, which has revealed previously unconsidered therapeutic targets in APS such as P-selectin glycoprotein ligand-1 (PSGL-1).